Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Sunshine Biopharma (SBFM) Asset Utilization Ratio (2018 - 2026)

Sunshine Biopharma filings provide 8 years of Asset Utilization Ratio readings, the most recent being 1.18 for Q4 2025.

  • On a quarterly basis, Asset Utilization Ratio rose 2.5% to 1.18 in Q4 2025 year-over-year; TTM through Dec 2025 was 1.18, a 2.5% increase, with the full-year FY2025 number at 1.2, down 0.59% from a year prior.
  • Asset Utilization Ratio hit 1.18 in Q4 2025 for Sunshine Biopharma, roughly flat from 1.18 in the prior quarter.
  • In the past five years, Asset Utilization Ratio ranged from a high of 1.21 in Q1 2025 to a low of 0.01 in Q3 2022.
  • Median Asset Utilization Ratio over the past 5 years was 0.63 (2023), compared with a mean of 0.59.
  • Biggest five-year swings in Asset Utilization Ratio: crashed 85.06% in 2022 and later surged 6027.84% in 2023.
  • Sunshine Biopharma's Asset Utilization Ratio stood at 0.1 in 2021, then grew by 27.67% to 0.12 in 2022, then surged by 606.75% to 0.88 in 2023, then soared by 31.33% to 1.15 in 2024, then grew by 2.5% to 1.18 in 2025.
  • The last three reported values for Asset Utilization Ratio were 1.18 (Q4 2025), 1.18 (Q3 2025), and 1.19 (Q2 2025) per Business Quant data.